Putative role of serum insulin-like growth factor -1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels in the development of prostate cancer in Arab men

Prostate Cancer and Prostatic Diseases

Volumn 8, Issue 1, 2005, Pages 84-90

  Kehinde, E O ^a   Akanji, A O ^a   Mojiminiyi, O A ^a   Bashir, A A ^b   Daar, A S ^c   Varghese, R ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b Central Blood Bank ^*  (Kuwait)

^c SULTAN QABOOS UNIVERSITY   (Oman)

Author keywords

Insulin like growth factor binding protein 3; Insulin like growth factor 1; Race

Indexed keywords

HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADOLESCENT; ADULT; AGED; ARAB; ARTICLE; BLOOD SAMPLING; CANCER GRADING; CANCER INCIDENCE; CANCER STAGING; CAUCASIAN; CONTROLLED STUDY; DIET RESTRICTION; HUMAN; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; NATIVE SPECIES; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROTEIN BLOOD LEVEL; VOLUNTEER; BLOOD; CASE CONTROL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; PROSTATE TUMOR; RADIOIMMUNOASSAY; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARABS; CASE-CONTROL STUDIES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RADIOIMMUNOASSAY; RISK FACTORS;

EID: 20444477134     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500783     Document Type: Article

References (42)

1. Parkins DM et al. Cancer Incidence in Fine Continents. IARC Scientific Publications, 1997, No143, Lyons, France, pp 5-10.
2. Macaulay VM. Insulin like growth factor and cancer. Br J Cancer 1992; 62: 311-320.
3. Cohen P, Peehl DM, Lamsom G, Rosenfield RG. Insulin like growth factor (IGFs), IGF-receptors and IGF binding proteins in primary culture of prostate epithelial cells. J Clin Endocrinol 1991; 73: 401-407.
4. Chan JM et al. Insulin like growth factor-1 and prostate cancer risk: A prospective study. Science 1998; 279: 563-566.
5. Wolk A et al. Insulin like growth factor, and prostate cancer risk: A population-based case control. J.N.C.I. 1998; 90: 911-915.
6. Scorilas A et al. Serum human glandular kallikrein (hk2) and insulin like growth factor-1 (IGF-1) improve the discrimination between prostate cancer and BPH in combination with total and % free PSA. Prostate 2003; 54: 220-229.
7. Chokkalingam AP et al. Insulin like growth factor and prostate cancer: A population-based case-control study in China. Cancer Epidemiol Biomarkers Prev 2001; 10: 421-426.
8. Khosravi J, Diamandi A, Mistry J, Scorilas A. Insulin-like growth factor 1 (IGF-1) and IGF-binding protein-3 in benign prostatic hyperplasia and prostate cancer. J Clin Endocrinol Metab 2001; 86: 694-701.
9. Djavan B et al. Insulin-like growth factor-1 (IGF-1), IGF-1 density, and IGF-1 PSA ratio for prostate cancer detection. Urology 1999; 54: 603-608.
10. Kurek R et al. The significance of serum levels of insulin-like growth factor-1 in patients with prostate cancer. Br J Urol Int 2002; 85: 125.
11. Cutting CW et al. Serum insulin-like growth factor-1 is not a useful marker of prostate cancer. Br J Urol Int 1999; 83: 996.
12. Finne P et al. Insulin-like growth factor-1 is not a useful marker of prostate cancer in men with elevated levels of prostate - specific antigen. J Clin Endocrinol Metab 2000; 85: 2744-2749.
13. Ismail HA et al. Insulin-like growth factor-1 and IGFBP3 for prostate cancer detection in patients undergoing prostate biopsy. J Urol 2002; 168: 2426-2430.
14. Stattin P et al. Plasma insulin-like growth factor-1 insulin-like growth factor-binding proteins, and prostate cancer risk: A prospective study. J Natl Cancer Inst 2000; 92: 1910-1914.
15. Harman SM et al. Serum levels of insulin-like growth factor I (IGF-1), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer. J Clin Endocrinol Metab 2000; 85: 4258-4263.
16. Pollak M. Insulin like growth factor and prostate cancer. Epedimiol Rev 2001; 23: 59-67.
17. Montzaros CS et al. Insulin like growth factor 1 in relation to prostate cancer and BPH. Br J Cancer 1997; 76: 1115-1118.
18. Schaefer C, Friedman GD. Insulin like growth factor-1 and prostate cancer. Science 1998; 282: 1999.
19. Juul A, Bang P, Herte NT. Serum IGF-1 in 1030 healthy children, adolescents and adults: Relation to age, sex, stage of puberty, testicular size and body mass index. J Clin Endocrinol Metab 1994; 78: 744-752.
20. Djavan B, Waldert M, Seitzl C, Marberger M. Insulin-like growth factor and prostate cancer. World J Urol 2001; 19: 225-233.
21. Grimberg A, Cohen P. Growth hormone and prostate cancer: Guilty by association? J Endocrinol Investig 1999; 22: 64-73.
22. Rosen CJ, Pollak M. Circulating IGF-1. New perspectives for a new century. Trends Endocrinol Metab 1999; 10: 136-141.
23. Grimberg A, Cohen P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 2000; 183: 1-9.
24. Pollak M, Beamer W, Zhang JC. Insulin-like growth factors and prostate cancer. Cancer Metastasis Rev 1999; 17: 383-390.
25. Rajah R, Valentinis B, Cohen P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem 1997; 272: 12181-12188.
26. Kelley KM et al. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol 1996; 28: 619-637.
27. Harman SM et al. Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer. J Clin Endocrinol Metab 2000; 85: 4258-4265.
28. Signorello LB et al. Insulin-like growth factor-binding protein-1 and prostate cancer. J Natl Cancer Inst 1999; 91: 1965-1967.
29. Wright NM et al. Demonstration of a lack of racial difference in secretion of growth hormone despite a racial difference in bone mineral density in premenouposal women - a clinic Research center study. J Clin Endocrinol Metab 1996; 81: 1023-1026.
30. Powell IJ. Prostate cancer and African-American men. Oncology (Huntingt) 1997; 11: 599-615.
31. Cohen P et al. Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J Endocrinol 1994; 142: 407-415.
32. Kanety H et al. Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: Correlation with serum prostate-specific antigen. J Clin Endocrinol Metab 1993; 77: 229-233.
33. Cohen P et al. Elevated levels of insulin-like growth factor binding protein-2 in the serum of prostate cancer patients. J Clin Endocrinol Metab 1993; 76: 1031-1035.
34. Ho PJ, Baxter RC. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia. Clin Endocrinol 1997; 46: 333-342.
35. Shariat SF, Lamb DJ, Kattan MW. Association of pre operative plasma levels of IGF-1 and IGFBP-3 with prostate cancer invasion, progression and metastasis. J Clin Oncol 2002; 20: 841-853.
36. Thissen JP, Ketelsegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev 1994; 15: 80-101.
37. Li L et al. Relation of serum insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 to risk of prostate cancer (United states). Cancer Causes Control 2003; 14: 721-726.
38. Renehan AG et al. Insulin-like growth factor (IGF-1), IGF binding protein-3 and cancer risk: Systematic review and meta-regression analysis. Lancet 2004; 363: 1346-1353.
39. Stattin P et al. High levels of circulating insulin-like growth factor-1 increase prostate cancer risk: A prospective study in a population-based non-screened cohort. J Clin Oncol 2004; 22: 3104-3112.
40. Madami KA. Food consumption patterns in Saudi Arabia. In: Musaiger AO, Milach SS (eds) Food Consumption Patterns and Dietary Habits in the Arab Countries of the Gulf. FAO Regional Office for the Near East, Cairo, 1995; pp 50-57.
41. Kehinde EO. Prostate cancer in the Middle East: Perspective from Oman. In: Belldegrum A, Kirby RS, Oliver RTD (eds) New Perspective in Prostate Cancer. ISIS Medical Media, Oxford, 1998; pp 383-390.
42. Hanash KA et al. Prostatic carcinoma: A nutritional disease? conflicting data from Kingdom of Saudi Arabia. J Urol 1999; 161 (Suppl): 71.